Vladimír Šámal

Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer

Kim N., Dana E. Rathkopf, Matthew R. Smith et al. · Journal of Clinical Oncology · 2023 · 319 citations · Full text

Medicine, Oncology, Urology +17

Efficacy and Safety of Autologous Dendritic Cell–Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer

Nicholas J. Vogelzang, Tomasz M. Beer, Winald R. Gerritsen et al. · JAMA Oncology · 2022 · 90 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Submucosal Administration of OnabotulinumtoxinA in the Treatment of Neurogenic Detrusor Overactivity: Pilot Single-Centre Experience and Comparison with Standard Injection into the Detrusor

Vladimír Šámal, Jan Mečl, Jaroslav Šrám · Urologia Internationalis · 2013 · 18 citations

Medicine, Pharmacology, Urology +17

The prevalence of antibiotic-resistant and multidrug-resistant bacteria in urine cultures from inpatients with spinal cord injuries and disorders: an 8-year, single-center study

Vladimír Šámal, Vít Paldus, Daniela Fáčková et al. · BMC Infectious Diseases · 2022 · 15 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

The expression of PD-L1 in patients with castrate prostate cancer treated with enzalutamide.

Igor Richter, Tomáš Jirásek, Ivana Havlickova et al. · PubMed · 2019 · 12 citations

Medicine, Oncology, Pharmacology +16